Project Experience: Chemotherapy Drugs

A large Pharmaceutical Manufacturer was interested in learning about their extended shelf-life of an injectable chemotherapy formulation. The main focus was to determine whether the primary degradation had in fact started to occur during storage. EMSL developed an assay that could monitor for the presence of the degradation product at 0.1% or less as required by regulatory using Ion Trap LC/MS/MS while providing rapid turnaround for the method in two weeks.